FDA Inspection 974966 — Carter BloodCare - Tyler
The FDA completed an inspection of Carter BloodCare - Tyler on June 1, 2016 in Tyler, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 1, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tyler, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 165 | 21 CFR 606.170(a) | Adverse reaction - Maintenance of Reports |
| 57 | 21 CFR 606.60(a) | Maintain and clean equipment |
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |